| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Islam | 23 | 2021 | 545 | 7.54 | Why? |
| Travel | 42 | 2021 | 7220 | 4.43 | Why? |
| Travel-Related Illness | 11 | 2020 | 1357 | 3.10 | Why? |
| Azithromycin | 18 | 2021 | 3943 | 2.76 | Why? |
| Rickettsia | 15 | 2019 | 101 | 2.69 | Why? |
| Respiratory Tract Infections | 16 | 2021 | 6817 | 2.46 | Why? |
| Crowding | 10 | 2021 | 731 | 2.36 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 13 | 2019 | 449 | 2.33 | Why? |
| Hydroxychloroquine | 20 | 2021 | 12447 | 2.05 | Why? |
| Saudi Arabia | 27 | 2021 | 4423 | 2.00 | Why? |
| Rabies | 5 | 2018 | 113 | 2.00 | Why? |
| Travel Medicine | 8 | 2019 | 335 | 1.97 | Why? |
| Chikungunya Fever | 6 | 2019 | 345 | 1.91 | Why? |
| France | 49 | 2021 | 12074 | 1.88 | Why? |
| Homeless Persons | 6 | 2021 | 1171 | 1.81 | Why? |
| Culicidae | 8 | 2018 | 239 | 1.75 | Why? |
| Insect Vectors | 9 | 2019 | 227 | 1.74 | Why? |
| DNA, Bacterial | 14 | 2019 | 835 | 1.72 | Why? |
| Bartonella | 7 | 2019 | 24 | 1.69 | Why? |
| Rickettsia Infections | 10 | 2019 | 58 | 1.56 | Why? |
| Carrier State | 6 | 2021 | 2100 | 1.55 | Why? |
| Pediculus | 3 | 2018 | 35 | 1.41 | Why? |
| Lice Infestations | 3 | 2018 | 39 | 1.41 | Why? |
| Senegal | 7 | 2021 | 283 | 1.36 | Why? |
| Bacteria | 9 | 2021 | 1897 | 1.35 | Why? |
| Chikungunya virus | 4 | 2019 | 339 | 1.30 | Why? |
| Borrelia | 5 | 2019 | 39 | 1.29 | Why? |
| Aedes | 5 | 2019 | 380 | 1.22 | Why? |
| Coxiella burnetii | 7 | 2018 | 120 | 1.18 | Why? |
| Dengue | 7 | 2019 | 1565 | 1.18 | Why? |
| Tick-Borne Diseases | 5 | 2019 | 68 | 1.17 | Why? |
| Sentinel Surveillance | 5 | 2019 | 1093 | 1.17 | Why? |
| Algeria | 13 | 2019 | 185 | 1.16 | Why? |
| Virus Diseases | 6 | 2019 | 3779 | 1.15 | Why? |
| Anopheles | 5 | 2018 | 89 | 1.13 | Why? |
| Q Fever | 5 | 2018 | 130 | 1.10 | Why? |
| Lyme Disease | 4 | 2019 | 102 | 1.09 | Why? |
| Viruses | 8 | 2021 | 2238 | 1.08 | Why? |
| Sports | 4 | 2021 | 690 | 1.08 | Why? |
| Skin Diseases, Parasitic | 2 | 2017 | 5 | 1.06 | Why? |
| Dirofilariasis | 3 | 2017 | 7 | 1.06 | Why? |
| Bacterial Infections | 5 | 2019 | 2229 | 1.03 | Why? |
| Communicable Diseases, Emerging | 6 | 2020 | 2523 | 1.01 | Why? |
| Malaria | 5 | 2019 | 1097 | 1.00 | Why? |
| Entomology | 4 | 2018 | 13 | 0.91 | Why? |
| Communicable Diseases | 5 | 2020 | 2148 | 0.89 | Why? |
| Malaria, Vivax | 2 | 2018 | 152 | 0.87 | Why? |
| Malaria, Falciparum | 3 | 2018 | 377 | 0.86 | Why? |
| Antimalarials | 9 | 2021 | 2505 | 0.84 | Why? |
| Anaplasmataceae | 3 | 2019 | 14 | 0.84 | Why? |
| Ticks | 4 | 2018 | 107 | 0.83 | Why? |
| Mosquito Vectors | 5 | 2019 | 351 | 0.83 | Why? |
| Bartonella Infections | 3 | 2019 | 18 | 0.82 | Why? |
| Respiration Disorders | 2 | 2016 | 526 | 0.82 | Why? |
| Antiviral Agents | 14 | 2021 | 41703 | 0.82 | Why? |
| Dirofilaria immitis | 3 | 2017 | 5 | 0.80 | Why? |
| Giardiasis | 1 | 2019 | 34 | 0.79 | Why? |
| Drug Synergism | 6 | 2021 | 833 | 0.76 | Why? |
| Anti-Bacterial Agents | 18 | 2021 | 10083 | 0.76 | Why? |
| Transients and Migrants | 4 | 2019 | 1468 | 0.72 | Why? |
| Larva Migrans | 1 | 2017 | 4 | 0.71 | Why? |
| Humans | 162 | 2021 | 930598 | 0.70 | Why? |
| Orientia tsutsugamushi | 2 | 2018 | 45 | 0.70 | Why? |
| Post-Exposure Prophylaxis | 3 | 2018 | 472 | 0.70 | Why? |
| Acinetobacter | 2 | 2018 | 58 | 0.70 | Why? |
| Lassa virus | 1 | 2018 | 99 | 0.70 | Why? |
| Polymerase Chain Reaction | 13 | 2020 | 6740 | 0.69 | Why? |
| Scrub Typhus | 2 | 2018 | 68 | 0.66 | Why? |
| Lassa Fever | 1 | 2018 | 88 | 0.66 | Why? |
| Enteritis | 1 | 2018 | 147 | 0.65 | Why? |
| Skin Diseases, Infectious | 1 | 2018 | 77 | 0.65 | Why? |
| Arbovirus Infections | 2 | 2018 | 104 | 0.64 | Why? |
| False Negative Reactions | 2 | 2020 | 1785 | 0.64 | Why? |
| Siphonaptera | 3 | 2018 | 21 | 0.63 | Why? |
| Animals | 55 | 2021 | 78931 | 0.62 | Why? |
| Boutonneuse Fever | 3 | 2018 | 21 | 0.60 | Why? |
| Aircraft | 1 | 2020 | 498 | 0.60 | Why? |
| Sheep | 4 | 2019 | 420 | 0.58 | Why? |
| Bites and Stings | 4 | 2018 | 91 | 0.58 | Why? |
| Disease Outbreaks | 12 | 2020 | 27595 | 0.57 | Why? |
| Thailand | 5 | 2019 | 1155 | 0.57 | Why? |
| Tick Bites | 3 | 2019 | 34 | 0.57 | Why? |
| Bartonella quintana | 3 | 2019 | 27 | 0.56 | Why? |
| Dermacentor | 2 | 2016 | 9 | 0.54 | Why? |
| Adult | 59 | 2021 | 244371 | 0.54 | Why? |
| Rectum | 1 | 2017 | 495 | 0.53 | Why? |
| Triatominae | 2 | 2017 | 5 | 0.53 | Why? |
| Middle Aged | 54 | 2021 | 270681 | 0.53 | Why? |
| Male | 67 | 2021 | 367725 | 0.52 | Why? |
| Drug Utilization | 1 | 2019 | 619 | 0.52 | Why? |
| Aged, 80 and over | 29 | 2021 | 88759 | 0.52 | Why? |
| RNA Virus Infections | 1 | 2015 | 231 | 0.52 | Why? |
| Arthropod Vectors | 2 | 2017 | 35 | 0.52 | Why? |
| Enterobacteriaceae | 1 | 2017 | 395 | 0.51 | Why? |
| Female | 71 | 2021 | 380317 | 0.51 | Why? |
| Aged | 46 | 2021 | 215776 | 0.50 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.49 | Why? |
| Bedbugs | 2 | 2019 | 7 | 0.49 | Why? |
| Pneumococcal Vaccines | 1 | 2018 | 571 | 0.48 | Why? |
| Drug Combinations | 6 | 2021 | 3852 | 0.48 | Why? |
| Ixodes | 2 | 2018 | 58 | 0.48 | Why? |
| Drug Repositioning | 7 | 2021 | 5683 | 0.48 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.46 | Why? |
| Anaplasma phagocytophilum | 2 | 2018 | 34 | 0.46 | Why? |
| Orthomyxoviridae | 3 | 2020 | 1168 | 0.46 | Why? |
| Coronavirus Infections | 27 | 2020 | 253789 | 0.46 | Why? |
| Young Adult | 28 | 2021 | 93724 | 0.45 | Why? |
| Potassium Channels, Voltage-Gated | 2 | 2018 | 13 | 0.45 | Why? |
| Ctenocephalides | 2 | 2018 | 11 | 0.45 | Why? |
| Enterobacteriaceae Infections | 1 | 2017 | 529 | 0.45 | Why? |
| Yellow Fever | 2 | 2018 | 231 | 0.45 | Why? |
| Dirofilaria repens | 2 | 2017 | 4 | 0.44 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 6 | 2020 | 8843 | 0.44 | Why? |
| Drug Resistance, Bacterial | 2 | 2019 | 1414 | 0.43 | Why? |
| beta-Lactamases | 1 | 2017 | 759 | 0.43 | Why? |
| Refugees | 1 | 2021 | 809 | 0.43 | Why? |
| Genotype | 7 | 2021 | 4697 | 0.42 | Why? |
| Drug Therapy, Combination | 8 | 2021 | 7268 | 0.42 | Why? |
| Scalp | 2 | 2019 | 82 | 0.41 | Why? |
| Ixodidae | 2 | 2011 | 37 | 0.41 | Why? |
| Drug Interactions | 4 | 2021 | 1653 | 0.41 | Why? |
| Blood | 2 | 2018 | 274 | 0.41 | Why? |
| Influenza, Human | 5 | 2017 | 10779 | 0.41 | Why? |
| Dog Diseases | 2 | 2017 | 745 | 0.41 | Why? |
| Fever | 5 | 2020 | 7795 | 0.41 | Why? |
| Hemorrhagic Fever, Ebola | 2 | 2018 | 1475 | 0.41 | Why? |
| Nasopharynx | 7 | 2021 | 10224 | 0.41 | Why? |
| Epidemiological Monitoring | 3 | 2020 | 3493 | 0.41 | Why? |
| Typhus, Endemic Flea-Borne | 2 | 2018 | 25 | 0.41 | Why? |
| Eritrea | 2 | 2019 | 17 | 0.40 | Why? |
| Densovirinae | 1 | 2018 | 9 | 0.40 | Why? |
| Referral and Consultation | 3 | 2020 | 4816 | 0.39 | Why? |
| Diptera | 1 | 2019 | 30 | 0.39 | Why? |
| Hyperkalemia | 2 | 2021 | 140 | 0.39 | Why? |
| Animal Distribution | 1 | 2018 | 23 | 0.39 | Why? |
| DNA, Kinetoplast | 1 | 2018 | 1 | 0.39 | Why? |
| Angiotensin I | 1 | 2021 | 200 | 0.38 | Why? |
| Adolescent | 26 | 2021 | 86841 | 0.38 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 8811 | 0.38 | Why? |
| Phlebotomus | 1 | 2018 | 11 | 0.38 | Why? |
| Abortion, Veterinary | 1 | 2018 | 10 | 0.38 | Why? |
| Horses | 2 | 2019 | 474 | 0.38 | Why? |
| Real-Time Polymerase Chain Reaction | 11 | 2020 | 11367 | 0.38 | Why? |
| Viral Load | 10 | 2021 | 15850 | 0.38 | Why? |
| Leishmania infantum | 1 | 2018 | 29 | 0.38 | Why? |
| Anoplura | 1 | 2018 | 2 | 0.37 | Why? |
| Flea Infestations | 1 | 2018 | 4 | 0.37 | Why? |
| Filarioidea | 1 | 2017 | 4 | 0.37 | Why? |
| Leishmaniasis | 1 | 2018 | 26 | 0.37 | Why? |
| Argasidae | 1 | 2017 | 3 | 0.37 | Why? |
| Tuberculosis, Pulmonary | 1 | 2019 | 1171 | 0.37 | Why? |
| Blotting, Western | 1 | 2021 | 863 | 0.36 | Why? |
| Child, Preschool | 15 | 2021 | 36283 | 0.36 | Why? |
| Hypokalemia | 2 | 2021 | 195 | 0.36 | Why? |
| Europe | 8 | 2019 | 12702 | 0.36 | Why? |
| Filariasis | 1 | 2017 | 18 | 0.36 | Why? |
| Relapsing Fever | 1 | 2017 | 14 | 0.36 | Why? |
| Rhipicephalus sanguineus | 1 | 2017 | 3 | 0.36 | Why? |
| Phthirus | 1 | 2017 | 1 | 0.36 | Why? |
| Insecta | 1 | 2018 | 122 | 0.36 | Why? |
| Permethrin | 1 | 2017 | 11 | 0.36 | Why? |
| Tokyo | 2 | 2021 | 645 | 0.36 | Why? |
| Cellulitis | 1 | 2019 | 119 | 0.36 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.36 | Why? |
| Neonicotinoids | 1 | 2017 | 14 | 0.35 | Why? |
| Insect Repellents | 1 | 2017 | 23 | 0.35 | Why? |
| RNA, Viral | 10 | 2021 | 32276 | 0.35 | Why? |
| Host-Parasite Interactions | 1 | 2018 | 112 | 0.35 | Why? |
| Cattle | 4 | 2018 | 1336 | 0.35 | Why? |
| Doxycycline | 5 | 2019 | 307 | 0.35 | Why? |
| Noncommunicable Diseases | 1 | 2017 | 934 | 0.35 | Why? |
| Piroplasmida | 1 | 2016 | 2 | 0.35 | Why? |
| Child | 20 | 2021 | 70012 | 0.34 | Why? |
| Rhipicephalus | 1 | 2016 | 14 | 0.34 | Why? |
| Leishmaniasis, Visceral | 1 | 2018 | 85 | 0.34 | Why? |
| Cattle Diseases | 2 | 2018 | 294 | 0.34 | Why? |
| Meals | 1 | 2018 | 205 | 0.33 | Why? |
| Nasal Mucosa | 1 | 2015 | 1218 | 0.33 | Why? |
| Nasal Cavity | 1 | 2013 | 909 | 0.33 | Why? |
| Extremities | 1 | 2018 | 179 | 0.33 | Why? |
| Blood Chemical Analysis | 2 | 2018 | 541 | 0.33 | Why? |
| Ruminants | 1 | 2016 | 52 | 0.33 | Why? |
| Sus scrofa | 1 | 2018 | 205 | 0.33 | Why? |
| Neck | 1 | 2019 | 307 | 0.32 | Why? |
| Long QT Syndrome | 3 | 2021 | 1047 | 0.32 | Why? |
| Prevalence | 10 | 2021 | 25773 | 0.32 | Why? |
| Hashimoto Disease | 1 | 2017 | 74 | 0.32 | Why? |
| Mosquito Control | 1 | 2018 | 237 | 0.32 | Why? |
| Breast | 1 | 2019 | 290 | 0.32 | Why? |
| Vitamin A | 1 | 2017 | 188 | 0.31 | Why? |
| Nitro Compounds | 1 | 2017 | 190 | 0.31 | Why? |
| Measles | 2 | 2018 | 608 | 0.31 | Why? |
| Calcinosis | 1 | 2019 | 240 | 0.31 | Why? |
| Health Status Indicators | 1 | 2009 | 341 | 0.31 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.30 | Why? |
| Meningitis | 1 | 2017 | 163 | 0.30 | Why? |
| Food Preferences | 1 | 2017 | 128 | 0.30 | Why? |
| Fluorescent Antibody Technique, Indirect | 3 | 2020 | 393 | 0.30 | Why? |
| Insecticides | 1 | 2017 | 178 | 0.30 | Why? |
| Angiotensin II | 1 | 2021 | 601 | 0.29 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2020 | 12361 | 0.29 | Why? |
| Dengue Virus | 4 | 2018 | 910 | 0.29 | Why? |
| Pneumonia, Viral | 16 | 2020 | 243684 | 0.29 | Why? |
| Communicable Disease Control | 9 | 2021 | 29620 | 0.28 | Why? |
| Coronavirus | 5 | 2014 | 18339 | 0.28 | Why? |
| Mammography | 1 | 2019 | 410 | 0.28 | Why? |
| Genotyping Techniques | 1 | 2017 | 360 | 0.27 | Why? |
| SARS Virus | 3 | 2020 | 13021 | 0.27 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.27 | Why? |
| Mali | 3 | 2018 | 181 | 0.26 | Why? |
| Insect Proteins | 2 | 2017 | 39 | 0.26 | Why? |
| Dogs | 5 | 2018 | 2529 | 0.26 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.26 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.26 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.26 | Why? |
| Risk | 5 | 2018 | 5288 | 0.25 | Why? |
| Betacoronavirus | 17 | 2020 | 204454 | 0.25 | Why? |
| Ecosystem | 1 | 2018 | 776 | 0.25 | Why? |
| Infant | 9 | 2021 | 30274 | 0.25 | Why? |
| Religion | 3 | 2018 | 353 | 0.25 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.25 | Why? |
| Lymphadenopathy | 1 | 2019 | 444 | 0.25 | Why? |
| Guanidines | 1 | 2017 | 499 | 0.25 | Why? |
| RNA, Ribosomal, 16S | 3 | 2018 | 793 | 0.24 | Why? |
| Seasons | 3 | 2021 | 4071 | 0.24 | Why? |
| Nairovirus | 1 | 2011 | 4 | 0.24 | Why? |
| Electrocardiography | 3 | 2021 | 3957 | 0.24 | Why? |
| Virus Shedding | 3 | 2021 | 5834 | 0.23 | Why? |
| Rhinovirus | 3 | 2020 | 979 | 0.23 | Why? |
| Gram-Negative Bacteria | 1 | 2016 | 473 | 0.23 | Why? |
| Middle East | 2 | 2019 | 1418 | 0.22 | Why? |
| Africa, Northern | 2 | 2016 | 539 | 0.22 | Why? |
| Pyridines | 1 | 2017 | 680 | 0.22 | Why? |
| Necrosis | 2 | 2018 | 532 | 0.22 | Why? |
| Gastrointestinal Diseases | 1 | 2016 | 2580 | 0.22 | Why? |
| Central African Republic | 1 | 2020 | 37 | 0.21 | Why? |
| Feeding Behavior | 3 | 2018 | 1909 | 0.21 | Why? |
| Rabies virus | 2 | 2018 | 92 | 0.21 | Why? |
| Plasmodium vivax | 1 | 2011 | 154 | 0.21 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.21 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.21 | Why? |
| Specimen Handling | 3 | 2020 | 6190 | 0.21 | Why? |
| Recurrence | 2 | 2020 | 3675 | 0.21 | Why? |
| Judaism | 1 | 2020 | 45 | 0.20 | Why? |
| Diagnosis, Differential | 5 | 2020 | 7220 | 0.20 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.20 | Why? |
| Students, Medical | 1 | 2019 | 4032 | 0.20 | Why? |
| Skin Diseases | 1 | 2016 | 2509 | 0.20 | Why? |
| Asymptomatic Infections | 1 | 2018 | 7218 | 0.20 | Why? |
| Vaccination | 7 | 2019 | 19050 | 0.19 | Why? |
| Encephalitis | 1 | 2017 | 797 | 0.19 | Why? |
| Species Specificity | 3 | 2018 | 1356 | 0.19 | Why? |
| Clinical Trials as Topic | 5 | 2021 | 7330 | 0.19 | Why? |
| Bartonella henselae | 2 | 2019 | 28 | 0.19 | Why? |
| Pandemics | 17 | 2021 | 389249 | 0.19 | Why? |
| Pupa | 2 | 2018 | 12 | 0.19 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.19 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.19 | Why? |
| Origin of Life | 1 | 2018 | 8 | 0.19 | Why? |
| Diagnostic Tests, Routine | 2 | 2019 | 2643 | 0.19 | Why? |
| Motion Sickness | 1 | 2018 | 5 | 0.19 | Why? |
| Disease Transmission, Infectious | 3 | 2019 | 9044 | 0.19 | Why? |
| Paracoccidioidomycosis | 1 | 2018 | 28 | 0.19 | Why? |
| Equidae | 2 | 2018 | 14 | 0.18 | Why? |
| Clinical Laboratory Techniques | 5 | 2020 | 23402 | 0.18 | Why? |
| Arthropods | 2 | 2018 | 27 | 0.18 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.18 | Why? |
| Vietnam | 3 | 2019 | 1665 | 0.18 | Why? |
| Coccidioidomycosis | 1 | 2018 | 47 | 0.18 | Why? |
| Geologic Sediments | 1 | 2018 | 43 | 0.18 | Why? |
| Magnesium | 1 | 2021 | 290 | 0.18 | Why? |
| Borrelia Infections | 2 | 2017 | 12 | 0.18 | Why? |
| Sequence Analysis, DNA | 4 | 2017 | 2830 | 0.18 | Why? |
| Risk Factors | 10 | 2020 | 71621 | 0.18 | Why? |
| Larva | 2 | 2018 | 153 | 0.18 | Why? |
| Bacterial Outer Membrane Proteins | 3 | 2018 | 60 | 0.17 | Why? |
| DNA, Helminth | 2 | 2017 | 15 | 0.17 | Why? |
| Administration, Oral | 4 | 2018 | 2340 | 0.17 | Why? |
| Surveys and Questionnaires | 4 | 2019 | 43792 | 0.17 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.17 | Why? |
| Histoplasmosis | 1 | 2018 | 83 | 0.17 | Why? |
| Prospective Studies | 8 | 2021 | 43301 | 0.17 | Why? |
| Placenta | 1 | 2018 | 1531 | 0.17 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2021 | 13720 | 0.17 | Why? |
| Arthralgia | 1 | 2019 | 173 | 0.17 | Why? |
| Iraq | 1 | 2017 | 177 | 0.17 | Why? |
| Rickettsia felis | 1 | 2006 | 5 | 0.16 | Why? |
| Games, Recreational | 1 | 2016 | 18 | 0.16 | Why? |
| Coinfection | 3 | 2020 | 6820 | 0.16 | Why? |
| Dengue Vaccines | 1 | 2018 | 123 | 0.16 | Why? |
| Plasmodium | 1 | 2017 | 74 | 0.16 | Why? |
| Africa, Western | 1 | 2018 | 363 | 0.16 | Why? |
| Health Planning Guidelines | 1 | 2017 | 133 | 0.16 | Why? |
| Goats | 2 | 2017 | 217 | 0.16 | Why? |
| Enterovirus | 1 | 2020 | 402 | 0.16 | Why? |
| West Nile Fever | 1 | 2019 | 166 | 0.16 | Why? |
| Yellow fever virus | 1 | 2018 | 205 | 0.16 | Why? |
| Football | 1 | 2018 | 120 | 0.16 | Why? |
| Relief Work | 1 | 2019 | 185 | 0.16 | Why? |
| Disease Vectors | 2 | 2019 | 208 | 0.16 | Why? |
| Bordetella pertussis | 1 | 2017 | 117 | 0.16 | Why? |
| Escherichia coli Proteins | 1 | 2017 | 168 | 0.16 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.16 | Why? |
| Treatment Outcome | 8 | 2021 | 51732 | 0.16 | Why? |
| Cohort Studies | 5 | 2019 | 36005 | 0.16 | Why? |
| Infant, Newborn | 5 | 2021 | 23105 | 0.16 | Why? |
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.15 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.15 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.15 | Why? |
| Health Status | 1 | 2009 | 3259 | 0.15 | Why? |
| Protective Devices | 1 | 2020 | 493 | 0.15 | Why? |
| Global Warming | 1 | 2017 | 93 | 0.15 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.15 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.15 | Why? |
| Patient Safety | 2 | 2021 | 4885 | 0.15 | Why? |
| Meningococcal Vaccines | 1 | 2018 | 225 | 0.15 | Why? |
| Measles Vaccine | 1 | 2018 | 301 | 0.15 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.15 | Why? |
| Chagas Disease | 1 | 2017 | 155 | 0.14 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.14 | Why? |
| Microtubules | 1 | 2014 | 47 | 0.14 | Why? |
| Meningococcal Infections | 1 | 2018 | 216 | 0.14 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.14 | Why? |
| Global Health | 8 | 2018 | 13911 | 0.14 | Why? |
| Endemic Diseases | 1 | 2019 | 480 | 0.14 | Why? |
| Indolizines | 1 | 2014 | 41 | 0.14 | Why? |
| Sputum | 2 | 2020 | 1720 | 0.14 | Why? |
| Whooping Cough | 1 | 2017 | 201 | 0.14 | Why? |
| Antiparasitic Agents | 1 | 2017 | 267 | 0.14 | Why? |
| Environmental Microbiology | 1 | 2019 | 575 | 0.14 | Why? |
| Cross-Sectional Studies | 6 | 2021 | 53120 | 0.14 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.14 | Why? |
| Indonesia | 1 | 2018 | 1022 | 0.14 | Why? |
| Symptom Assessment | 2 | 2020 | 4967 | 0.13 | Why? |
| Patient Discharge | 2 | 2020 | 5696 | 0.13 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.13 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.13 | Why? |
| Rupicapra | 1 | 2012 | 2 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Chemoprevention | 1 | 2018 | 585 | 0.13 | Why? |
| Hospital Administration | 1 | 2020 | 650 | 0.13 | Why? |
| Tobacco Smoking | 1 | 2017 | 349 | 0.13 | Why? |
| DNA Primers | 3 | 2017 | 1170 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Water | 1 | 2018 | 765 | 0.12 | Why? |
| Tick Infestations | 2 | 2018 | 26 | 0.12 | Why? |
| Influenza A virus | 2 | 2015 | 2234 | 0.12 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.12 | Why? |
| Holidays | 1 | 2016 | 311 | 0.12 | Why? |
| Phylogeny | 6 | 2021 | 13341 | 0.12 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.12 | Why? |
| Milk | 1 | 2013 | 158 | 0.12 | Why? |
| Camelus | 2 | 2018 | 1425 | 0.12 | Why? |
| Africa | 2 | 2018 | 2986 | 0.12 | Why? |
| Hand Sanitizers | 1 | 2018 | 397 | 0.12 | Why? |
| Chickens | 2 | 2018 | 1010 | 0.11 | Why? |
| Rodentia | 2 | 2017 | 235 | 0.11 | Why? |
| Pericarditis | 1 | 2016 | 417 | 0.11 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.11 | Why? |
| Nigeria | 1 | 2018 | 2292 | 0.11 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.10 | Why? |
| Public Health Surveillance | 2 | 2014 | 3129 | 0.10 | Why? |
| Reproducibility of Results | 3 | 2019 | 11304 | 0.10 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.10 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.10 | Why? |
| Rickettsia conorii | 1 | 1998 | 7 | 0.10 | Why? |
| Rickettsia typhi | 1 | 1998 | 7 | 0.10 | Why? |
| Phthiraptera | 1 | 2018 | 6 | 0.10 | Why? |
| Nervous System Diseases | 1 | 2018 | 4092 | 0.10 | Why? |
| Zika Virus Infection | 2 | 2017 | 1920 | 0.10 | Why? |
| Monitoring, Physiologic | 1 | 2021 | 1956 | 0.10 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.10 | Why? |
| Borrelia burgdorferi Group | 1 | 2018 | 12 | 0.10 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.10 | Why? |
| Proteomics | 3 | 2017 | 2481 | 0.10 | Why? |
| Typhus, Epidemic Louse-Borne | 1 | 2018 | 17 | 0.10 | Why? |
| Coronaviridae | 1 | 2015 | 923 | 0.10 | Why? |
| Cytochromes b | 1 | 2018 | 23 | 0.09 | Why? |
| Felidae | 1 | 2018 | 23 | 0.09 | Why? |
| Elephantiasis, Filarial | 1 | 2019 | 47 | 0.09 | Why? |
| Mites | 1 | 2018 | 26 | 0.09 | Why? |
| Brugia pahangi | 1 | 2017 | 2 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 1454 | 0.09 | Why? |
| Brugia malayi | 1 | 2017 | 4 | 0.09 | Why? |
| Malaria, Cerebral | 1 | 2018 | 37 | 0.09 | Why? |
| Pacific Islands | 1 | 2018 | 152 | 0.09 | Why? |
| Ornithodoros | 1 | 2017 | 3 | 0.09 | Why? |
| Panthera | 1 | 2018 | 42 | 0.09 | Why? |
| Anaplasmataceae Infections | 1 | 2017 | 7 | 0.09 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.09 | Why? |
| Exanthema | 2 | 2018 | 1097 | 0.09 | Why? |
| Erythrocebus patas | 1 | 2017 | 2 | 0.09 | Why? |
| Perissodactyla | 1 | 2017 | 4 | 0.09 | Why? |
| Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.09 | Why? |
| Asia | 1 | 2016 | 2399 | 0.09 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.09 | Why? |
| Long-Term Care | 1 | 2020 | 2047 | 0.09 | Why? |
| Dairying | 1 | 2018 | 46 | 0.09 | Why? |
| Climate Change | 1 | 2017 | 901 | 0.09 | Why? |
| Climate | 2 | 2018 | 557 | 0.09 | Why? |
| Biomedical Research | 2 | 2017 | 5270 | 0.09 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.09 | Why? |
| Passeriformes | 1 | 2017 | 14 | 0.09 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.09 | Why? |
| Forests | 1 | 2019 | 132 | 0.09 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.09 | Why? |
| Papio | 1 | 2018 | 104 | 0.09 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.09 | Why? |
| Genes, Mitochondrial | 1 | 2017 | 14 | 0.09 | Why? |
| Bacterial Proteins | 2 | 2017 | 1318 | 0.09 | Why? |
| Automation, Laboratory | 1 | 2021 | 536 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Hand Disinfection | 1 | 2018 | 1671 | 0.09 | Why? |
| Sheep, Domestic | 1 | 2016 | 18 | 0.09 | Why? |
| Anaplasma ovis | 1 | 2016 | 3 | 0.09 | Why? |
| Culex | 1 | 2018 | 66 | 0.09 | Why? |
| Theileriasis | 1 | 2016 | 7 | 0.09 | Why? |
| Theileria | 1 | 2016 | 8 | 0.09 | Why? |
| Ivermectin | 1 | 2017 | 973 | 0.09 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.09 | Why? |
| Babesia | 1 | 2016 | 15 | 0.08 | Why? |
| Cameroon | 1 | 2019 | 464 | 0.08 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.08 | Why? |
| Anaplasmosis | 1 | 2016 | 21 | 0.08 | Why? |
| Babesiosis | 1 | 2016 | 22 | 0.08 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.08 | Why? |
| Paper | 1 | 2017 | 74 | 0.08 | Why? |
| Bacterial Typing Techniques | 1 | 2018 | 273 | 0.08 | Why? |
| History, 21st Century | 1 | 2014 | 1849 | 0.08 | Why? |
| Croatia | 1 | 2018 | 360 | 0.08 | Why? |
| Environmental Monitoring | 1 | 2019 | 3143 | 0.08 | Why? |
| Insect Bites and Stings | 1 | 2017 | 63 | 0.08 | Why? |
| Goat Diseases | 1 | 2016 | 36 | 0.08 | Why? |
| Hedgehogs | 1 | 2016 | 56 | 0.08 | Why? |
| Guideline Adherence | 1 | 2020 | 2309 | 0.08 | Why? |
| Health Education | 1 | 2018 | 1539 | 0.08 | Why? |
| Sheep Diseases | 1 | 2016 | 55 | 0.08 | Why? |
| Administration, Cutaneous | 1 | 2017 | 229 | 0.08 | Why? |
| Farms | 1 | 2018 | 269 | 0.08 | Why? |
| Antibodies, Antinuclear | 1 | 2018 | 234 | 0.08 | Why? |
| Personnel, Hospital | 1 | 2020 | 2273 | 0.08 | Why? |
| French Guiana | 2 | 2017 | 83 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.08 | Why? |
| Callithrix | 1 | 2017 | 288 | 0.08 | Why? |
| Antigens, Bacterial | 1 | 2019 | 330 | 0.08 | Why? |
| Cities | 2 | 2018 | 4937 | 0.07 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.07 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.07 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.07 | Why? |
| Age Distribution | 2 | 2018 | 3567 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Animals, Wild | 2 | 2018 | 1028 | 0.07 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.07 | Why? |
| Antibodies, Bacterial | 1 | 1998 | 510 | 0.07 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.07 | Why? |
| Pathology, Molecular | 1 | 2018 | 343 | 0.07 | Why? |
| Incidental Findings | 1 | 2019 | 487 | 0.07 | Why? |
| Mammals | 1 | 2016 | 315 | 0.07 | Why? |
| Haplotypes | 1 | 2018 | 853 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Antibiotic Prophylaxis | 1 | 2017 | 399 | 0.07 | Why? |
| Epidemics | 3 | 2021 | 6407 | 0.07 | Why? |
| Interviews as Topic | 1 | 2013 | 1952 | 0.07 | Why? |
| Molecular Epidemiology | 2 | 2021 | 1638 | 0.07 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.07 | Why? |
| Asymptomatic Diseases | 2 | 2020 | 3444 | 0.06 | Why? |
| Melanoma | 1 | 2014 | 1229 | 0.06 | Why? |
| Syndrome | 1 | 2018 | 1310 | 0.06 | Why? |
| Population Density | 1 | 2018 | 694 | 0.06 | Why? |
| Republic of Korea | 1 | 2016 | 5858 | 0.06 | Why? |
| Fecal Microbiota Transplantation | 1 | 2017 | 372 | 0.06 | Why? |
| Family | 1 | 2017 | 2909 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Endocarditis, Bacterial | 1 | 2017 | 344 | 0.06 | Why? |
| Chad | 1 | 2011 | 25 | 0.06 | Why? |
| Neurons | 1 | 2018 | 864 | 0.06 | Why? |
| Health Surveys | 1 | 2013 | 2841 | 0.06 | Why? |
| Skin | 2 | 2018 | 2096 | 0.06 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.06 | Why? |
| Arachnid Vectors | 1 | 2011 | 24 | 0.06 | Why? |
| Cough | 2 | 2020 | 4891 | 0.06 | Why? |
| Quinine | 1 | 2011 | 56 | 0.06 | Why? |
| Cat Diseases | 1 | 2018 | 539 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.06 | Why? |
| DNA | 1 | 2017 | 778 | 0.06 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.06 | Why? |
| Cats | 1 | 2018 | 1890 | 0.05 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.05 | Why? |
| Smell | 1 | 2020 | 1851 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Limit of Detection | 1 | 2019 | 2698 | 0.05 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.05 | Why? |
| Bunyaviridae Infections | 1 | 2011 | 107 | 0.05 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.05 | Why? |
| Chronic Disease | 2 | 2017 | 5139 | 0.05 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.05 | Why? |
| Rats | 1 | 2017 | 2764 | 0.05 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.05 | Why? |
| Citrate (si)-Synthase | 1 | 2008 | 10 | 0.05 | Why? |
| Swine | 1 | 2018 | 3352 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Population Surveillance | 1 | 2016 | 4967 | 0.05 | Why? |
| Romania | 1 | 2011 | 590 | 0.05 | Why? |
| Volcanic Eruptions | 1 | 2018 | 7 | 0.05 | Why? |
| United Kingdom | 1 | 2019 | 18046 | 0.05 | Why? |
| Brazil | 1 | 2016 | 12582 | 0.05 | Why? |
| Silicates | 1 | 2018 | 19 | 0.05 | Why? |
| World Health Organization | 3 | 2018 | 4213 | 0.05 | Why? |
| Dose-Response Relationship, Drug | 2 | 2021 | 3776 | 0.05 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.05 | Why? |
| Antineoplastic Agents | 1 | 2014 | 3550 | 0.05 | Why? |
| Mass Vaccination | 1 | 2018 | 1101 | 0.04 | Why? |
| Statistics as Topic | 1 | 2021 | 370 | 0.04 | Why? |
| West Nile virus | 1 | 2019 | 206 | 0.04 | Why? |
| Mink | 1 | 2021 | 399 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Chiroptera | 2 | 2017 | 3530 | 0.04 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.04 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.04 | Why? |
| Morocco | 1 | 2008 | 449 | 0.04 | Why? |
| Yellow Fever Vaccine | 1 | 2018 | 198 | 0.04 | Why? |
| Respiratory Rate | 1 | 2020 | 691 | 0.04 | Why? |
| Finland | 1 | 2019 | 671 | 0.04 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.04 | Why? |
| China | 2 | 2021 | 50654 | 0.04 | Why? |
| Trypanosoma cruzi | 1 | 2017 | 133 | 0.04 | Why? |
| Americas | 1 | 2017 | 418 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2017 | 390 | 0.04 | Why? |
| Methylprednisolone | 1 | 2017 | 2107 | 0.04 | Why? |
| Burkina Faso | 1 | 2016 | 302 | 0.04 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.04 | Why? |
| Research | 1 | 2019 | 2115 | 0.04 | Why? |
| Africa South of the Sahara | 1 | 2021 | 1335 | 0.04 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.04 | Why? |
| Sex Factors | 1 | 2013 | 11014 | 0.04 | Why? |
| Foxes | 1 | 2014 | 5 | 0.04 | Why? |
| Lyssavirus | 1 | 2014 | 10 | 0.04 | Why? |
| Rhabdoviridae Infections | 1 | 2014 | 23 | 0.04 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2014 | 138 | 0.04 | Why? |
| Peru | 1 | 2019 | 1010 | 0.04 | Why? |
| Greece | 1 | 2011 | 2091 | 0.03 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Serologic Tests | 1 | 2019 | 4359 | 0.03 | Why? |
| Russia | 1 | 2018 | 989 | 0.03 | Why? |
| Rabies Vaccines | 1 | 2014 | 106 | 0.03 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Influenza Vaccines | 1 | 2009 | 2941 | 0.03 | Why? |
| Italy | 2 | 2018 | 38444 | 0.03 | Why? |
| Tuberculosis | 1 | 2019 | 2895 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Mycoses | 1 | 2018 | 589 | 0.03 | Why? |
| Schools | 1 | 2017 | 4187 | 0.03 | Why? |
| Malpractice | 1 | 2014 | 165 | 0.03 | Why? |
| Pets | 1 | 2014 | 314 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2018 | 1649 | 0.03 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.03 | Why? |
| Sexually Transmitted Diseases | 1 | 2018 | 694 | 0.03 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.02 | Why? |
| Mauritania | 1 | 1998 | 39 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.02 | Why? |
| Molecular Structure | 1 | 2014 | 1539 | 0.02 | Why? |
| Vaccination Coverage | 1 | 2018 | 1249 | 0.02 | Why? |
| Students | 1 | 2017 | 5255 | 0.02 | Why? |
| Income | 1 | 2018 | 1564 | 0.02 | Why? |
| Commerce | 1 | 2018 | 1109 | 0.02 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.02 | Why? |
| Structure-Activity Relationship | 1 | 2014 | 2219 | 0.02 | Why? |
| Mice | 1 | 2017 | 21357 | 0.02 | Why? |
| Cell Proliferation | 1 | 2014 | 1973 | 0.02 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2014 | 3608 | 0.02 | Why? |
| Antibody Formation | 1 | 2018 | 4038 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2014 | 1672 | 0.02 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| HIV Infections | 1 | 2019 | 11620 | 0.02 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.02 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Zoonoses | 1 | 2014 | 3034 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Immunization, Passive | 1 | 2014 | 10067 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Blood Donors | 1 | 1998 | 2956 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 1998 | 10017 | 0.01 | Why? |